Clinical trial
Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache
NCT00399243 · Diamond Headache Clinic, Other · Unknown status
Key facts
| NCT number | NCT00399243 |
|---|---|
| Title | Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache |
| Official title | 4mg StatDose Imitrex for Acute Treatment of Cluster Headache |
| Lead sponsor | Diamond Headache Clinic, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Episodic Cluster Headache, Chronic Cluster Headache |
| Intervention type | Drug |
| Interventions | Sumatriptan 4mg Statdose injection |
| Enrollment | 20 |
| Start date | Nov 1, 2006 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Nov 14, 2006 |
| Last update posted | Feb 2, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: